Pharmaceutical companies also see growingdemand for these super generics, leading to investment and ramping productioncapabilities. As patient demand for enhanced therapies rises, the supergenerics segment is expected to grow significantly. The prescription drugs segment held revenue of USD 4.1 billion in 2023 and the segment is poised for significant growth at a CAGR of 27.1% during the forecast period.
Anti-Obesity Drugs Market Restraints: Challenges Impeding Growth In The Market
One dynamic that we and investors will be closely monitoring is the potential tailwind to branded GLP-1 drugs for obesity when compounded versions can no longer be sold in the US, as of May 22, 2025. There are estimated to be at least 1 million patients currently on compounded GLP-1s in the US. We expect that a large number of these patients could switch to branded versions, helping the near-term growth trajectory for the current incumbents.
- Manufacturers of generic pharmaceuticals have consistently concentrated on the research and introduction of new novel medications and formulations, such as biosimilars, which is driving market growth.
- Furthermore, the rising cost of branded medicines, increase in healthcare expenditure, and growing demand of generic drugs contributes to the growth of Generic Drugs Market Size.
- Currently, North America is projected to capture 70% of the anti-obesity drugs market share.
- Many companies are also increasing investments in research and development to create safer, more effective OTC products with fewer side effects.
- The orphan segment is anticipated to grow at a comparatively higher CAGR over the forecast period.
Generic Drugs Market Geographical Analysis
They contain the same active ingredients as their brand-name counterparts, ensuring similar therapeutic effects at a fraction of the cost. Moreover, healthcare providers often prioritize using generic drugs for chronic disease management due to their proven safety and efficacy. They may prescribe generics as a first-line treatment option or encourage patients to switch from brand-name medications to their generic equivalents to improve adherence and reduce costs. In addition, the payers, including insurance companies and government programs, recognize the cost-saving potential of generic drugs in chronic disease management.
What Is Covered Under Pharmaceutical Packaging Equipment Market?
In January 2023, Sun Pharmaceutical Industries Ltd. launched the generic version of palbociclib, Pfizer Inc.’s breast cancer medicine, in India. The entry of the generic version of the drug was possible after the expiration of the company’s Indian patent on the product. This launch ensured the affordability of the drug in the country, aiding in improving patient accessibility and combating breast cancer, which is one of the most common forms of cancer in India. As per the estimates of the Global Cancer Observatory (GCO), India had approximately 98,337 female deaths related to breast cancer in 2022. North America dominates the generic drug market due to the region’s established framework for the approval process of generic medications and global leaders in research and development activities. Super generics are expected to grow with the fastest CAGR in the generic drugs market because they are a better version of expired-brand medicines at significantly lower prices.
- Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., and Sun Pharmaceutical Industries Ltd. are some of the prominent companies in the injectable drug market.
- Pharmaceutical companies are actively exploring diverse drug combinations to develop more comprehensive and effective treatment options.
- The growth is attributed to tablets offering a convenient and familiar form of medication, making them user-friendly for consumers.
- Government initiatives and technological advancements in diagnostics and therapeutics further support the market expansion among the geriatric population.
- This growth is driven by the growing awareness among consumers, convenience, and affordability of OTC drugs over prescription drugs.
- Recently, the approved pembrolizumab (Keytruda) has been increasingly employed in different cancer types, like locally advanced head and neck cancers.
Key Market Drivers, Trends, And Forecast For The Global Gene-Editing Transfection Chemicals Industry
The offline channels segment is sub-segmented into hospital pharmacies, retail pharmacies, and other offline channels. The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. The value of goods in this market includes related services sold by the creators of the goods. The U.S. pharmaceutical market remains the global benchmark due to its concentration of innovation-driven companies and a highly regulated yet conducive environment for drug development and commercialization.
US Over The Counter Drugs Market Share
The hospital pharmacy segment is expected to hold the largest market share during the forecast period. The primary reason behind the segment’s dominance is that a significantly large number of drugs have to be administered at hospitals intravenously by trained healthcare professionals. The retail pharmacy segment is expected to register a comparatively lower CAGR during the forecast period. The increasing demand for personalized medicine further supports market growth, as consumers seek tailored treatment options that align with their specific health needs. Further, the expanding market for telemedicine and digital health platforms has facilitated access to weight management programs, integrating pharmaceutical interventions with lifestyle modifications. Due to the presence of various large- and small-scale enterprises distributed across the globe, the global generic pharmaceuticals market is fragmented.
Table Of Contents For Generic Drugs Industry Report
Nevertheless, inflation-linked input costs and upcoming price negotiation clauses will test profitability, pressuring companies to automate quality control, diversify suppliers, and optimize route-to-market economics. Several regions across the globe faced challenges in accessing medical care and treatment due to the escalation of country restrictions or lockdowns. These factors also limited the number of patient visits to hospitals, and the dispersion of prescriptions by healthcare professionals, further moderately limiting the demand and adoption of prescription drugs. Also, the disruption caused by the COVID-19 pandemic to international supply chains led to high-profile shortages of critical medications and decline in drug expenditures across the globe. On the basis of route of administration, the prescription drugs market is segmented into oral, topical, parenteral, and others. The oral segment accounted for the largest revenue share of 51.2% in 2024, due to ease of use and widespread application in chronic disease management.
This preference is primarily due to the direct introduction of drugs into the bloodstream, ensuring rapid absorption and immediate therapeutic effect. Biologics and biosimilars represent a significant and fast-growing segment within the injectable market. The increasing availability of biosimilar injectables is helping reduce treatment costs and expand patient access globally. Furthermore, ongoing innovations in formulation, such as sustained-release injectables and combination therapies, are enhancing treatment outcomes and convenience.
PHARMACEUTICAL MARKET SIZE AND SHARE ANALYSIS – GROWTH TRENDS AND FORECASTS (2025-
Increasing R&D initiatives and rising advocacy by patients’ groups for effective treatment are propelling the introduction of newer and more effective product offerings. These trends have led to the development and marketing of several blockbuster drugs for the treatment of many types of cancers, immunological diseases, and other rare disorders. The OTC drugs market is segmented based on distribution channels into hospitals, retail, and online pharmacies.
The affordability of generic CNS medications increases patient access to essential treatments and contributes to the growth of the generic drug market. One of the prominent trends in the global market is strong product launches for these disease indications. Globally, patients suffering from rare diseases are seeking efficient and potent treatment for these disorders.
This increase in treatment rates represents a positive step towards prioritizing mental health in the United States. However, additional effort is needed to ensure that everyone receives the care they require. The rising mental health conditions and increased demand for mental health treatments ultimately foster the anti-psychotic drugs market. Regionally, North America and Europe dominate the market due to well-established healthcare systems, high healthcare expenditure, and greater adoption of advanced therapeutics. However, Asia Pacific is emerging as the fastest-growing region, propelled by improving healthcare access, increasing incidence of chronic diseases, and expanding pharmaceutical manufacturing capabilities. Injectable drugs play a crucial role in the treatment of various conditions including oncology, diabetes, autoimmune disorders, and infectious diseases.
It is produced and marketed after the patent protection of the original brand-name drug expires. These medications contain the same active ingredients as their brand-name counterparts and undergo rigorous testing by regulatory authorities to ensure their quality, safety, and effectiveness. Generic drugs offer several advantages, including lower cost, increased accessibility, and greater affordability, making healthcare more affordable and accessible to a wider population. They play a crucial role in providing cost-effective alternatives to brand-name drugs, promoting competition in the pharmaceutical market, and enhancing the overall efficiency of healthcare systems in the United States. The global market size is distributed across various active compounds used in the medication.
Across the world, there is a major growth in chronic diseases like cardiovascular issues, diabetes, obesity, and cancer, which are driving the growth of the drugs market. Further, the growing awareness about health and hygiene, along with increasing capital, is impacting demand for superior hospitals, drugs, and pharmacy offerings. Drugs are substances other than food, derived from natural, synthetic, or semisynthetic sources, containing active pharmaceutical ingredients (API) and excipients, to achieve their pharmacological activity in the body. They are utilized in mild to severe illness conditions to relieve the pain or issues in patients suffering from different normal or abnormal symptoms.
